For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Outlook Therapeutics Inc (NASDAQ: OTLK) closed at $2.04 in the last session, up 2.00% from day before closing price of $2.0. In other words, the price has increased by $2.00 from its previous closing price. On the day, 0.54 million shares were traded. OTLK stock price reached its highest trading level at $2.05 during the session, while it also had its lowest trading level at $1.98.
Ratios:
We take a closer look at OTLK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.72.
On March 27, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $50.
Chardan Capital Markets Upgraded its Neutral to Buy on February 15, 2024, while the target price for the stock was maintained at $3.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 26 ’24 when KENYON LAWRENCE A bought 5,000 shares for $5.69 per share. The transaction valued at 28,446 led to the insider holds 5,946 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OTLK now has a Market Capitalization of 87421544 and an Enterprise Value of 94240840.
Stock Price History:
The Beta on a monthly basis for OTLK is 0.28, which has changed by -0.745 over the last 52 weeks, in comparison to a change of 0.16932249 over the same period for the S&P500. Over the past 52 weeks, OTLK has reached a high of $8.70, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is 10.25%, while the 200-Day Moving Average is calculated to be -15.52%.
Shares Statistics:
According to the various share statistics, OTLK traded on average about 774.02K shares per day over the past 3-months and 870880 shares per day over the past 10 days. A total of 32.91M shares are outstanding, with a floating share count of 26.43M. Insiders hold about 38.31% of the company’s shares, while institutions hold 16.63% stake in the company. Shares short for OTLK as of 1752537600 were 2023374 with a Short Ratio of 2.61, compared to 1749772800 on 2739054. Therefore, it implies a Short% of Shares Outstanding of 2023374 and a Short% of Float of 5.7800002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Outlook Therapeutics Inc (OTLK) is currently drawing attention from 2.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.13 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$1.4 and -$2.08 for the fiscal current year, implying an average EPS of -$1.74. EPS for the following year is -$1.22, with 3.0 analysts recommending between -$0.95 and -$1.55.
Revenue Estimates
For the next quarter, 4 analysts are estimating revenue of $6.51M. There is a high estimate of $8.7M for the next quarter, whereas the lowest estimate is $3M.
Based on 5 analysts’ estimates, the company’s revenue will be $34.97M in the next fiscal year. The high estimate is $50.95M and the low estimate is $17.1M.
